Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
The temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggests a window-of-opportunity for checkpoint inhibitor therapy in prostate cancer.
Journal: medRxiv : the preprint server for health sciences
Published: February 06, 2026
DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 08, 2026
PSMA/PET-guided stereotactic radiosurgery treatment for intracranial metastases from prostate cancer.
Journal: Discover oncology
Published: August 01, 2025
Cell-resolved high-dimensional imaging analysis, therapeutic modeling, and a Phase Ib clinical study establish BCL-2 as a target across heterogeneous CRPC subtypes.
Journal: bioRxiv : the preprint server for biology
Published: July 17, 2025
Single-cell imaging analysis, therapeutic modeling and a Phase Ib trial validate BCL-2 as a target across heterogeneous castration-resistant prostate cancer.
Journal: Signal transduction and targeted therapy
Published: July 17, 2025
Increasing Cancer Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient Survival.
Journal: bioRxiv : the preprint server for biology
Published: June 03, 2025
Increasing Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient Survival.
Journal: bioRxiv : the preprint server for biology
Published: June 03, 2025
Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer.
Journal: Cancer chemotherapy and pharmacology
Published: May 23, 2025
Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate Cancer.
Journal: medRxiv : the preprint server for health sciences
Published: May 02, 2025
Treatment of advanced urothelial cancer with nivolumab plus chemotherapy versus chemotherapy alone (CheckMate 901 study): a plain language summary.
Journal: Future oncology (London, England)
Published: January 16, 2025
Role of Neoadjuvant Immunotherapy in Genitourinary Malignancies.
Journal: Cancers
Published: October 08, 2024
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.
Journal: The New England journal of medicine
Published: September 16, 2024
Last Updated: 09/26/2026